Αποτελέσματα Αναζήτησης
23 Απρ 2019 · Three evidence-based guidelines and one systematic review of guidelines were identified providing recommendations on the use of prescription monitoring programs for optimizing medication use and preventing harm.
1 Ιουν 2023 · Characteristics of included systematic reviews of prescription drug monitoring programs (PDMPs). To identify common barriers to accessing PDMP data. Pharmacists’ attitudes and knowledge of PDMPs had positive influence on likelihood of PDMP use. Most studies were quantitative (70%), or reviews (11%).
5 Δεκ 2018 · Prescription drug monitoring programs (PDMPs) are being implemented throughout the country as a decision support for prescribers, pharmacists and regulators. PDMPs are electronic databases that collect and analyze patient prescription data.
21 Μαΐ 2020 · After applying the cost-benefit model, the cost avoidance for TDM in each drug, per patient, was the following: vancomycin 900.92 ($990.97, USD), amikacin 1114.80 ($1226.82), and gentamicin 1257 ($1382.64). The cost of performing TDM in one patient (pharmacist time + laboratory test) is 35 ($38.50).
20 Ιουν 2017 · Prescription drug monitoring programs (PDMPs) have been implemented in 49 out of 50 states in an effort to reduce opioid-related misuse, abuse, and mortality, yet the literature evaluating the impact of PDMP implementation remains limited.
1 Νοε 2019 · The effectiveness of prescription drug monitoring programs at reducing opioid-related harms and consequences: a systematic review. Emily Rhodes, Maria Wilson, Alysia Robinson, Jill A. Hayden & Mark Asbridge. BMC Health Services Research 19, Article number: 784 (2019) Cite this article. 13k Accesses. 77 Citations. 21 Altmetric. Metrics. Abstract.
Purpose of review. Nearly every U.S. state operates a prescription drug monitoring program (PDMP) to monitor dispensing of controlled substances. These programs are often considered key policy levers in the ongoing polydrug epidemic.
